通过专为投资者打造的一站式数据看板，全面查看 Fulcrum Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

252.19M

股息TTM

0.00

市盈率 TTM

-3.30

每股收益TTM

-1.15

营业收入

0.00

净利润

-9.72M

净资产收益率

-27.10%

总资产收益率

-25.83%

Fulcrum Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

-24.13%-0.34

12.28%-0.25

-14.39%-0.31

9.96%-0.31

-131.05%-0.28

34.82%-0.28

32.48%-0.27

10.51%-0.35

331.44%0.89

-4.48%-0.43

20.16%-0.40

---0.39

---0.38

---0.41

---0.50

----

营业收入

----

--0.00

-100.00%0.00

----

-100.00%0.00

8990.91%80.00M

-100.00%0.00

27.15%871.00K

-35.84%759.00K

-53.24%880.00K

-88.62%295.00K

-86.46%685.00K

-76.03%1.18M

-57.04%1.88M

-45.88%2.59M

19.72%5.06M

167.05%4.94M

净利润

-51.36%-26.18M

-7.00%-18.89M

-22.73%-20.33M

9.68%-19.59M

-131.22%-17.30M

34.29%-17.66M

33.07%-16.57M

9.66%-21.70M

332.98%55.41M

-8.44%-26.87M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-11.29%-26.14M

-14.59%-23.74M

-73.40%-34.07M

-52.53%-25.93M

-32.53%-23.48M

-9.25%-20.72M

利润率

----

102.56%69.26%

----

25.50%-2842.25%

---3164.30%

---2702.61%

---8399.66%

---3815.33%

----

毛利率

----

0.00%100.00%

----

0.00%100.00%

--100.00%

----

利润表

营业收入

----

--0.00

-100.00%0.00

----

-100.00%0.00

8990.91%80.00M

-100.00%0.00

27.15%871.00K

-35.84%759.00K

-53.24%880.00K

-88.62%295.00K

-86.46%685.00K

-76.03%1.18M

-57.04%1.88M

-45.88%2.59M

19.72%5.06M

167.05%4.94M

营业利润

-0.97%-19.91M

-10.36%-22.19M

-16.80%-22.69M

5.22%-21.86M

-137.56%-19.71M

32.62%-20.10M

30.59%-19.43M

15.95%-23.06M

292.33%52.49M

-6.78%-29.83M

0.07%-27.99M

-14.86%-27.44M

20.28%-27.29M

-7.47%-27.94M

-18.90%-28.01M

-15.02%-23.89M

-73.94%-34.23M

-52.54%-26.00M

-32.45%-23.56M

-8.72%-20.77M

净利润

-51.36%-26.18M

-7.00%-18.89M

-22.73%-20.33M

9.68%-19.59M

-131.22%-17.30M

34.29%-17.66M

33.07%-16.57M

9.66%-21.70M

332.98%55.41M

-8.44%-26.87M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-11.29%-26.14M

-14.59%-23.74M

-73.40%-34.07M

-52.53%-25.93M

-32.53%-23.48M

-9.25%-20.72M

资产负债表

流动资产

47.17%322.85M

45.63%338.67M

43.04%357.48M

-23.04%205.86M

-21.73%219.37M

6.70%232.56M

3.19%249.92M

1.90%267.49M

-0.94%280.29M

-28.03%217.95M

16.71%242.20M

15.27%262.49M

62.38%282.95M

51.37%302.83M

-8.18%207.52M

-7.50%227.73M

35.59%174.25M

36.11%200.06M

89.10%226.00M

86.35%246.19M

流动负债总额

14.61%10.30M

21.78%9.86M

18.15%13.05M

-19.83%11.63M

-29.25%8.98M

-24.26%8.10M

-19.24%11.04M

3.08%14.51M

-14.22%12.70M

-25.77%10.69M

-18.24%13.68M

-4.25%14.07M

-33.08%14.80M

-21.22%14.41M

-12.89%16.73M

-28.64%14.70M

-1.73%22.12M

-19.19%18.29M

-28.16%19.20M

-22.14%20.60M

总资产

41.56%323.95M

42.91%346.77M

40.49%366.28M

-22.99%214.86M

-22.23%228.84M

4.33%242.65M

1.17%260.72M

0.05%279.01M

-2.02%294.26M

-27.57%232.59M

13.68%257.69M

12.54%278.88M

53.83%300.33M

45.80%321.12M

-3.54%226.69M

-3.03%247.81M

41.60%195.23M

40.76%220.25M

81.36%235.00M

79.69%255.55M

总负债

-8.33%13.26M

-4.91%13.47M

-2.26%17.28M

-24.06%16.49M

-29.35%14.46M

-25.44%14.16M

-21.41%17.68M

-7.26%21.72M

-17.82%20.47M

-23.60%19.00M

-18.89%22.50M

-11.27%23.42M

-27.77%24.90M

-20.02%24.86M

18.25%27.74M

5.83%26.39M

27.75%34.48M

8.24%31.09M

-31.79%23.46M

-33.02%24.94M

总权益

44.93%310.70M

45.87%333.30M

43.60%349.00M

-22.90%198.37M

-21.70%214.38M

6.97%228.49M

3.33%243.03M

0.72%257.29M

-0.59%273.79M

-27.90%213.59M

18.22%235.19M

15.38%255.46M

71.33%275.43M

56.62%296.26M

-5.95%198.94M

-3.99%221.41M

44.97%160.75M

48.07%189.16M

122.25%211.54M

119.66%230.61M

现金流量表

经营净额

-16.06%-16.04M

-22.89%-18.75M

-0.22%-16.80M

25.60%-14.19M

-123.46%-13.82M

39.66%-15.26M

27.62%-16.76M

16.74%-19.07M

383.37%58.90M

-4.84%-25.28M

-17.58%-23.16M

17.85%-22.91M

24.05%-20.79M

-9.09%-24.12M

9.89%-19.70M

-23.52%-27.88M

-53.56%-27.37M

-36.24%-22.11M

-10.25%-21.86M

-401.18%-22.57M

投资净额

-1.11%13.78M

-16400.64%-128.21M

-146.42%-1.05M

327.86%18.61M

211.39%13.93M

-102.04%-777.00K

-87.69%2.26M

-77.13%4.35M

-162.93%-12.51M

140.59%38.13M

150.48%18.35M

934.58%19.02M

-36.69%19.88M

-577.85%-93.94M

-299.85%-36.36M

97.86%-2.28M

219.13%31.39M

58.35%19.66M

37.70%-9.09M

-856.82%-106.64M

融资净额

18.27%356.00K

---312.00K

202673.49%168.30M

-89.92%64.00K

-20.16%301.00K

-100.00%0.00

-71.08%83.00K

--635.00K

165.49%377.00K

-98.60%1.65M

31.65%287.00K

-100.00%0.00

-94.95%142.00K

33719.83%117.69M

-75.53%218.00K

-41.30%80.95M

1244.98%2.81M

-99.27%348.00K

-85.76%891.00K

166248.19%137.90M

常见问题

Fulcrum Therapeutics Inc的流动资产是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，流动资产为357.48M（同比变化43.04）。

Fulcrum Therapeutics Inc的总资产是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，Fulcrum Therapeutics Inc的总资产为366.28M（同比变化40.49）。

Fulcrum Therapeutics Inc的总负债是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，Fulcrum Therapeutics Inc的总负债为17.28M（同比变化-2.26）。

Fulcrum Therapeutics Inc的总权益是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，Fulcrum Therapeutics Inc的总权益为349.00M（同比变化43.60）。

Fulcrum Therapeutics Inc的净营业收入是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，Fulcrum Therapeutics Inc的净营业收入为-84.37M（同比变化-325.38）。

Fulcrum Therapeutics Inc的净投资是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，Fulcrum Therapeutics Inc的净投资为30.72M（同比变化-4.69）。

Fulcrum Therapeutics Inc的净融资是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，Fulcrum Therapeutics Inc的净融资为168.67M（同比变化6042.28）。

Fulcrum Therapeutics Inc的每股收益（EPS）是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，每股收益（EPS）为-1.18（同比变化-653.29）。

Fulcrum Therapeutics Inc的净利润是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，净利润为-74.88M（同比变化-669.97）。

Fulcrum Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-25.30（同比变化-521.96）。

Fulcrum Therapeutics Inc的资产回报率（ROA）是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，资产回报率（ROA）为-23.89（同比变化-536.62）。

Fulcrum Therapeutics Inc的营业利润是多少？



根据Fulcrum Therapeutics Inc的FY2025财报，营业利润为-84.37M（同比变化-325.38）。